RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Liquidmetal® Technologies, Inc. (OTCQB: LQMT), the world’s leading developer of amorphous alloys, announced today it is shipping a pre-production order to CoNextions Medical for a key component to be used for suture based tendon repairs. The initial parts delivery will be used to complete various testing and will be followed by a full production shipment currently scheduled for early next year. This delivery represents the ongoing manufacturing solutions for CoNextions design efforts that are taking advantage of the Liquidmetal materials and molding technology.
About Liquidmetal Technologies
Liquidmetal Technologies, Inc. is the leading developer of amorphous alloys that utilize the performance advantages offered by amorphous alloy technology. Amorphous alloys are unique materials that are distinguished by their ability to retain a random structure when they solidify, in contrast to the crystalline atomic structure that forms in ordinary metals and alloys. Liquidmetal Technologies is the first company to produce amorphous alloys in commercially viable bulk form, enabling significant improvements in products across a wide array of industries. For more information, go to www.liquidmetal.com.
About CoNextions Medical
Founded in 2011, CoNextions Medical, Inc. is a privately held company located in Sandy, Utah. They are an innovation-based medical device company dedicated to achieving safer, stronger, and more durable tendon repairs worldwide marked by faster rehabilitation, fewer complications and lower long-term costs.